Common use of Collaborations Clause in Contracts

Collaborations. If a manuscript resulting from the Research Project has Study Investigators as co-authors, then the manuscript will be reviewed by SPIROMICS and SOURCE. 7.1.a If the manuscript is approved by SPIROMICS and/or SOURCE, the Recipient and Recipient’s PI agree to include the following language in an acknowledgment. “The Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) is funded by the National Heart, Lung, and Blood Institute (NHLBI) (HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C, U01 HL137880, U24 HL141762, and R01 HL182622).” “SPIROMICS Study of Early COPD Progression (SOURCE) is funded by the National Heart, Lung, and Blood Institute (NHLBI) (R01 HL144718).” 7.1.b If the manuscript is not approved by the SPIROMICS and/or SOURCE studies and the Recipient and Recipient’s PI wish to proceed to publish without inclusion of Study Investigators as co-authors, the Recipient and Recipient’s PI agree to include the following language in an acknowledgment. “The Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) is funded by the National Heart, Lung, and Blood Institute (NHLBI) (HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C, U01 HL137880, U24 HL141762, and R01 HL182622). “SPIROMICS Study of Early COPD Progression (SOURCE) is funded by the National Heart, Lung, and Blood Institute (NHLBI) (R01 HL144718).” “The opinions and conclusions contained in this publication are solely those of the authors, and are not endorsed by SPIROMICS, SOURCE, or the NHLBI and should not be assumed to reflect the opinions or conclusions of either.”

Collaborations. If a manuscript resulting from the Research Project has Study Investigators as co-authors, then the manuscript will be reviewed by SPIROMICS and SOURCEthe CHS. 7.1.a If the manuscript is approved by SPIROMICS and/or SOURCEthe CHS, the Recipient and Recipient’s PI agree to include the following language in an acknowledgment. “"The Subpopulations and Intermediate Outcomes in COPD Cardiovascular Health Study (SPIROMICSCHS) is funded supported by contracts HHSN268201200036C, HHSN268200800007C, N01 HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086 and NHLBI grants U01HL080295 and U01HL130114, with additional contribution from NINDS. Additional support was provided through AG-023629 from the National Heart, Lung, and Blood Institute (NHLBI) (HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C, U01 HL137880, U24 HL141762, and R01 HL182622)NIA. See also ▇▇▇▇▇://▇▇▇-▇▇▇▇▇.▇▇▇/pubs/PubAcknowGuidelines.” “SPIROMICS Study This manuscript has been reviewed by CHS for scientific content and consistency of Early COPD Progression (SOURCE) is funded by the National Heart, Lung, and Blood Institute (NHLBI) (R01 HL144718)data interpretation with previous CHS publications.” 7.1.b If the manuscript is not approved by the SPIROMICS and/or SOURCE studies CHS and the Recipient and Recipient’s PI wish to proceed to publish without inclusion of Study Investigators as co-authors, the Recipient and Recipient’s PI agree to include the following language in an acknowledgment. “"The Subpopulations and Intermediate Outcomes in COPD Cardiovascular Health Study (SPIROMICSCHS) is funded supported by contracts 75N92021D00006, HHSN268201200036C, HHSN268200800007C, N01 HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086 and NHLBI grants U01HL080295 and U01HL130114, with additional contribution from NINDS. Additional support was provided through AG-023629 from the National Heart, Lung, and Blood Institute (NHLBI) (HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C, U01 HL137880, U24 HL141762, and R01 HL182622)NIA. “SPIROMICS Study of Early COPD Progression (SOURCE) is funded by the National Heart, Lung, and Blood Institute (NHLBI) (R01 HL144718)See also ▇▇▇▇▇://▇▇▇-▇▇▇▇▇.▇▇▇/pubs/PubAcknowGuidelines.” “This manuscript was not approved by the CHS. The opinions and conclusions contained in this publication are solely those of the authors, and are not endorsed by SPIROMICS, SOURCE, the CHS or the NHLBI and should not be assumed to reflect the opinions or conclusions of either.”

Collaborations. If a manuscript resulting from the Research Project has Study Investigators as co-authors, then the manuscript will must be reviewed submitted for review by SPIROMICS and SOURCEthe CHS. 7.1.a If the manuscript is approved by SPIROMICS and/or SOURCEthe CHS, the Recipient and Recipient’s PI agree to include the following language in an acknowledgment. “The Subpopulations Cardiovascular Health Study is supported by contracts 75N92021D00006, HHSN268201200036C, HHSN268200800007C, N01 HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086 and Intermediate Outcomes in COPD Study (SPIROMICS) is funded by NHLBI grants U01HL080295 and U01HL130114, with additional contribution from NINDS. Additional support was provided through AG-023629 from the National Heart, Lung, and Blood Institute (NHLBI) (HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C, U01 HL137880, U24 HL141762, and R01 HL182622)NIA. See also ▇▇▇▇▇://▇▇▇-▇▇▇▇▇.▇▇▇/pubs/PubAcknowGuidelines.” “SPIROMICS Study This manuscript has been reviewed by CHS for scientific content and consistency of Early COPD Progression (SOURCE) is funded by the National Heart, Lung, and Blood Institute (NHLBI) (R01 HL144718)data interpretation with previous CHS publications.” 7.1.b If the manuscript is not approved by the SPIROMICS and/or SOURCE studies CHS and the Recipient and Recipient’s PI wish to proceed to publish without inclusion of Study Investigators as co-authors, the Recipient and Recipient’s PI agree to include the following language in an acknowledgment. “The Subpopulations Cardiovascular Health Study is supported by contracts 75N92021D00006, HHSN268201200036C, HHSN268200800007C, N01 HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086 and Intermediate Outcomes in COPD Study (SPIROMICS) is funded by NHLBI grants U01HL080295 and U01HL130114, with additional contribution from NINDS. Additional support was provided through AG-023629 from the National Heart, Lung, and Blood Institute (NHLBI) (HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C, U01 HL137880, U24 HL141762, and R01 HL182622)NIA. “SPIROMICS Study of Early COPD Progression (SOURCE) is funded by the National Heart, Lung, and Blood Institute (NHLBI) (R01 HL144718)See also ▇▇▇▇▇://▇▇▇-▇▇▇▇▇.▇▇▇/pubs/PubAcknowGuidelines.” “This manuscript was not approved by the CHS. The opinions and conclusions contained in this publication are solely those of the authors, and are not endorsed by SPIROMICS, SOURCE, the CHS or the NHLBI and should not be assumed to reflect the opinions or conclusions of either.”

Collaborations. If a manuscript resulting from the Research Project has Study Investigators as co-authors, then the manuscript will must be reviewed submitted for review by SPIROMICS and SOURCEthe Framingham Heart Study. 7.1.a If the manuscript is approved by SPIROMICS and/or SOURCEthe FHS, the Recipient and Recipient’s PI agree to include the following language in an acknowledgment. “"The Subpopulations and Intermediate Outcomes in COPD Framingham Heart Study (SPIROMICS) is funded supported by 75N92019D00031 from the National Heart, Lung, and Blood Institute (NHLBI) (HHSN268200900013Cwith additional support from HHSN268201500001, HHSN268200900014CR01HL107385, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C, U01 HL137880, U24 HL141762U19AG023122, and R01 HL182622)N01HC251952.” “SPIROMICS This manuscript has been reviewed by Framingham Heart Study of Early COPD Progression (SOURCE) is funded by the National Heart, Lung, and Blood Institute (NHLBI) (R01 HL144718)for scientific content.” 7.1.b If the manuscript is not approved by the SPIROMICS and/or SOURCE studies Framingham Heart Study and the Recipient and Recipient’s PI wish to proceed to publish without inclusion of Study Investigators as co-authors, the Recipient and Recipient’s PI agree to include the following language in an acknowledgment. “The Subpopulations and Intermediate Outcomes in COPD Framingham Heart Study (SPIROMICS) is funded supported by 75N92019D00031 from the National Heart, Lung, and Blood Institute (NHLBI) (HHSN268200900013Cwith additional support from HHSN268201500001, HHSN268200900014CR01HL107385, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C, U01 HL137880, U24 HL141762U19AG023122, and R01 HL182622). “SPIROMICS Study of Early COPD Progression (SOURCE) is funded by the National Heart, Lung, and Blood Institute (NHLBI) (R01 HL144718)N01HC251952.” “This manuscript was not approved by the Framingham Heart Study. The opinions and conclusions contained in this publication are solely those of the authors, and are not endorsed by SPIROMICS, SOURCE, the FHS or the NHLBI and should not be assumed to reflect the opinions or conclusions of either.”

Collaborations. If a manuscript resulting from the Research Project has Study Investigators as co-authors, then the manuscript will must be reviewed submitted for review by SPIROMICS and SOURCEthe CHS. 7.1.a If the manuscript is approved by SPIROMICS and/or SOURCEthe CHS, the Recipient and Recipient’s PI agree to include the following language in an acknowledgment. “The Subpopulations "This research was supported by contracts HHSN268201200036C, HHSN268200800007C, HHSN268201800001C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, 75N92021D00006, and Intermediate Outcomes in COPD Study (SPIROMICS) is funded by grants U01HL080295 and U01HL130114 from the National Heart, Lung, and Blood Institute (NHLBI) (HHSN268200900013C), HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C, U01 HL137880, U24 HL141762, and R01 HL182622).” “SPIROMICS Study of Early COPD Progression (SOURCE) is funded by with additional contribution from the National Heart, Lung, Institute of Neurological Disorders and Blood Stroke (NINDS). Additional support was provided by R01AG023629 from the National Institute on Aging (NHLBI) (R01 HL144718NIA). A full list of principal CHS investigators and institutions can be found at ▇▇▇-▇▇▇▇▇.▇▇▇." “This manuscript has been reviewed by CHS for scientific content.” 7.1.b If the manuscript is not approved by the SPIROMICS and/or SOURCE studies CHS and the Recipient and Recipient’s PI wish to proceed to publish without inclusion of Study Investigators as co-authors, the Recipient and Recipient’s PI agree to include the following language in an acknowledgment. “The Subpopulations This research was supported by contracts HHSN268201200036C, HHSN268200800007C, HHSN268201800001C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, 75N92021D00006, and Intermediate Outcomes in COPD Study (SPIROMICS) is funded by grants U01HL080295 and U01HL130114 from the National Heart, Lung, and Blood Institute (NHLBI) ), with additional contribution from the National Institute of Neurological Disorders and Stroke (HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C, U01 HL137880, U24 HL141762, and R01 HL182622NINDS). Additional support was provided by R01AG023629 from the National Institute on Aging (NIA). A full list of principal CHS investigators and institutions can be found at ▇▇▇-▇▇▇▇▇.▇▇▇." “SPIROMICS Study of Early COPD Progression (SOURCE) is funded This manuscript was not approved by the National Heart, Lung, and Blood Institute (NHLBI) (R01 HL144718).” “CHS. The opinions and conclusions contained in this publication are solely those of the authors, and are not endorsed by SPIROMICS, SOURCE, the CHS or the NHLBI and should not be assumed to reflect the opinions or conclusions of either.”